NSRS — Medcann Industries Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.04m
- -$0.03m
Annual income statement for Medcann Industries, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2010 April 30th | 2011 April 30th | 2018 April 30th | 2019 April 30th | |
|---|---|---|---|---|
| Period Length: | 11 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 8-K | 8-K |
| Standards: | USG | USG | — | — |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0 | 0 |
| Cost of Revenue | ||||
| Gross Profit | — | — | -0.01 | 0 |
| Selling / General / Administrative Expenses | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 0.001 | 0.047 | -0.558 | 0.041 |
| Operating Profit | -0.001 | -0.047 | 0.558 | -0.041 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -0.001 | -0.047 | 0.558 | -0.047 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.001 | -0.047 | 0.558 | -0.047 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.001 | -0.047 | 0.558 | -0.047 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Dilution Adjustment | ||||
| Diluted Net Income | -0.001 | -0.047 | 0.558 | -0.047 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.01 | -0.534 | -0 | -0 |
| Dividends per Share |